Innovative People
Paul Rennert
Biotechnology, drug development, developing research and business plans for biotechnology companies, licensing opportunities and review, monoclonal antibody development, small molecule development (particularly GPCR and kinases), immunology, autoimmune disease, in vivo models of disease.